CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Hypercalcaemia - Management
Basis for recommendation
Admit if the person has hypercalcaemia that is severe or symptomatic
Referral to an endocrinologist if primary hyperparathyroidism or familial hypocalciuric hypercalcaemia (FHH) are suspected
- When primary hyperparathyroidism or FHH are suspected, because of increased parathyroid hormone levels in the context of hypercalcaemia, referral to an endocrinologist is required (for confirmation of the diagnosis, assessment for the need for parathyroidectomy, and referral to a parathyroid surgeon or, if appropriate, conservative management) [Bilezikian et al, 2009; Eastell et al, 2009; Khan et al, 2009; Silverberg et al, 2009; Udelsman et al, 2009]. This requires experience and expertise in the management of people with primary hyperparathyroidism or FHH. For more information, see Secondary care.
© NHS Institute for Innovation and Improvement